dual _-opioid receptor agonist, _1 antagonist

oral analgesia w/ reduced opioid AEs, in Ph. I

from literature cmpd pharmacophore merging

J. Med. Chem., Oct. 16, 2020

ESTEVE Pharmaceuticals SA, Barcelona, ES

Structure of EST73502

“EST73502” (ESTEVE oral dual mu-opioid receptor agonist, sigma-1 receptor antagonist clinical candidate)

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: